Based on our findings, the elevation of serum levels of VIP and PACAP was observed in patients with EMs but TRPV1 levels were higher in the serum samples of patients suffering from CMs when compared to the healthy subjects. This evidence concerns the gene TRPV1 and congenital myasthenic syndrome.